curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

by palligoelme@gmail.com | Jun 12, 2025 | Clinical Trials

​ Conditions: Kidney Disease, Chronic; Diabetes; Dialysis; End Stage Kidney Disease (ESRD) Interventions: Drug: Semaglutide Pen Sponsors: Unity Health Toronto Not yet recruiting Conditions: Kidney Disease, Chronic; Diabetes; Dialysis; End Stage Kidney Disease (ESRD)...

Uroflowmetry Curve Types and IPSS in Men With LUTS

by palligoelme@gmail.com | Jun 12, 2025 | Clinical Trials

​ Conditions: Lower Urinary Tract Symptoms (LUTS); Benign Prostatic Hyperplasia (BPH); Voiding Dysfunction Sponsors: Tarik Emre Sener Not yet recruiting Conditions: Lower Urinary Tract Symptoms (LUTS); Benign Prostatic Hyperplasia (BPH); Voiding Dysfunction Sponsors:...

Determine the Clinical Effectiveness of Mobile CenteringPregnancy to Improve Maternal and Infant Health Outcomes of Marshallese in Arkansas

by palligoelme@gmail.com | Jun 12, 2025 | Clinical Trials

​ Conditions: Prenatal Care Interventions: Behavioral: CenteringPregnancy Sponsors: University of Arkansas; National Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS) Recruiting Conditions: Prenatal Care Interventions: Behavioral:...

The Combined First Trimester Screening

by palligoelme@gmail.com | Jun 11, 2025 | Clinical Trials

​ Conditions: Preeclampsia (PE); Fetal Growth Restriction; Congenital Abnormalities; Preterm Labor; Intrauterine Fetal Demise; Genetics Syndrome; Pregnancy Overdue – Week 41+6 Sponsors: Institute of Health Information and Statistics of the Czech Republic;...

Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis

by palligoelme@gmail.com | Jun 11, 2025 | Clinical Trials

​ Conditions: Myositis; Dermatomyositis Interventions: Drug: Deucravacitinb Sponsors: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Not yet recruiting Conditions: Myositis; Dermatomyositis Interventions: Drug: Deucravacitinb Sponsors:...
« Older Entries
Next Entries »

Recent Posts

  • Prospective Lifespan Cohort of Myocardial Infarction
  • Skin Involvement in Dupuytren Surgical Treatment Outcome
  • Frequency of MAFLD and Its Association With Nutritional Status and Metabolic Risk Factors in a Rural Population of Bangladesh
  • Piloting a Learning Collaborative for School-Based Bilingual Providers Delivering Evidence-Based Interventions
  • Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®